Intrepida Bio Overview

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Intrepida Bio General Information

Description

Developer of cancer medicines designed to modulate the innate immune system to fight cancer and other diseases. The company's medicines are designed using proprietary monoclonal antibodies that block the novel targets and its receptor as well as thwart their ability to create a favorable environment for tumor growth, enabling patients to get innovative treatments to cure cancer.

Contact Information

Website
www.intrepidabio.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 533 2nd Street
  • Suite 342
  • Encinitas, CA 92024
  • United States
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 533 2nd Street
  • Suite 342
  • Encinitas, CA 92024
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Intrepida Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 15-Dec-2021 Completed Out of Business
1. Early Stage VC (Series B) 22-Oct-2019 Completed Generating Revenue
To view Intrepida Bio’s complete valuation and funding history, request access »

Intrepida Bio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A
To view Intrepida Bio’s complete cap table history, request access »

Intrepida Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of cancer medicines designed to modulate the innate immune system to fight cancer and other diseases. The comp
Drug Discovery
Encinitas, CA

Woburn, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Intrepida Bio Competitors (1)

One of Intrepida Bio’s competitors is Bioss Antibodies, a Corporation company based in Woburn, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bioss Antibodies Corporation Woburn, MA
You’re viewing 1 of 1 competitors. Get the full list »

Intrepida Bio Patents

  • 7

    Total Documents Applications and Grants

  • Total Patents Families

  • 6

    Granted

  • Pending

  • Expiring in next 12 mo

Intrepida Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20210024623-A1 Anti-bag3 antibodies as therapeutic reagent in cardiovascular disease Inactive 28-Jul-2017
ES-2808947-T3 Humanized anti-bag3 antibodies Active 05-Nov-2015
EP-3371216-A1 Humanized anti-bag3 antibodies Active 05-Nov-2015
EP-3371216-B1 Humanized anti-bag3 antibodies Active 05-Nov-2015
ES-2795981-T3 Bag3 as a serum and tissue biochemical marker Active 19-Jun-2012 C07K16/18
To view Intrepida Bio’s complete patent history, request access »

Ready to get started?

Request a free trial

Intrepida Bio FAQs

  • Where is Intrepida Bio headquartered?

    Intrepida Bio is headquartered in Encinitas, CA.

  • What industry is Intrepida Bio in?

    Intrepida Bio’s primary industry is Drug Discovery.

  • Is Intrepida Bio a private or public company?

    Intrepida Bio is a Private company.

  • What is Intrepida Bio’s current revenue?

    The current revenue for Intrepida Bio is .

  • How much funding has Intrepida Bio raised over time?

    Intrepida Bio has raised $9.5M.

  • Who are Intrepida Bio’s competitors?

    Bioss Antibodies is a competitor of Intrepida Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »